PNT(Delisted)
POINT Biopharma·NASDAQ
--
--(--)
PNT fundamentals
POINT Biopharma (PNT) released its earnings on Aug 13, 2021: revenue was -- (YoY 0.00%), beat estimates; EPS was -- (YoY 0.00%), met estimates.
Revenue / YoY
--
0.00%
EPS / YoY
--
0.00%
Report date
Aug 13, 2021
EPS
Revenue
Revenue & Expenses
PNT has released its 2023 Q3 earnings report, with revenue of 2.79M, reflecting a YoY change of NaN%, and net profit of -24.77M, showing a YoY change of -3.17%. The Sankey diagram below clearly presents PNT's revenue sources and cost distribution.
Key Indicators
POINT Biopharma (PNT) key financial stats and ratios, covering profitability, financial health, and leverage.
POINT Biopharma (PNT)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
POINT Biopharma (PNT)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
POINT Biopharma (PNT)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does POINT Biopharma (PNT) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track POINT Biopharma (PNT) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
No Data
